ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1957

Dysregulation of CC Chemokines at Microvascular Endothelial Cells of Blood and Lymphatic Vessels Under Inflammatory Conditions

Lisa Rump-Goodrich1, Ayman Askari2, Derek Mattey3 and Jim Middleton4, 1Arthritis Research centre, Keele University, Gobowen, United Kingdom, 2Rheumatology, Robert Jones and Agnes Orthopaedic Hospital, Gobowen, United Kingdom, 3Keele University, Stoke-on-Trent, United Kingdom, 4Bristol university, Bristol, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: chemokines, endothelial cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Inflammation in the rheumatoid arthritis (RA) synovium is directly associated with inflammatory cell migration across microvasculature endothelial cells (ECs), and their persistence within the synovium.

It has been shown that lymphatic vessel chemokine presentation increases in RA and so should increase the removal of the interstitial fluid containing the invading inflammatory cells which are at significant levels within the fluid.  However, dysregulation of chemokine presentation between RA blood vessel and lymphatic vessel ECs may lead to reductions in removal of the ever increasing joint interstitial fluid and persistance of the inflammatory cells.

Methods: Immunohistochemistry was performed on human synovial tissue to using the pan-endothelial cell marker von-Willebrand factor, and the lymphatic EC marker LYVE-1 to assess the presence of CCL7, CCL14, CCL16 and CCL22.The number of vessels positive for each marker and the chemokine were counted to a maximum if 15 vessels over three fields of view (FOV) from 8 RA and 6 on-RA samples. Transmigration  of mononuclear cells  isolated from RA blood was performed over confluent human dermal lymphatic EC (HDLEC) monolayers in response to human CCL7 and analysed by FACS analysis. Inflammatory conditions were stimulated by activating overnight with 100ng/mL 100ng/mL TNF-α with 100ng/mL IFN-γ 

Results: Significant increases in CCL14 and CCL22 were obsereved in RA blood vessel ECs compared to non-RA ECs (P=0.0041 and 0.014 respectively). A significant decrease in CCL7 in RA lymphatic ECs compared to non-RA| lymphatic ECs was observed (p = 0.011). Furthermore, significant increases in RA monocyte migration were observed in response to CCL7 (p = 0.002). The greatest increase to be at 250ng/ml CCL7 (p = 0.013) with a significant increase in monocyte migration also seen at 100ng/ml CCL7 (p = 0.037) compared to 0ng/ml.

Conclusion: The significant decrease of CCL7 in lymphatic ECs, combined with it having the greatest chemotactic ability for monocytes for the tested chemokines suggests CCL7 may be of importance in lymphatic removal of infiltrates in the inflamed RA synovium. Reduction in CCL7 may  therefore be functional in leukocyte persistence and accumulation in the RA synovium.


Disclosure:

L. Rump-Goodrich,
None;

A. Askari,
None;

D. Mattey,
None;

J. Middleton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dysregulation-of-cc-chemokines-at-microvascular-endothelial-cells-of-blood-and-lymphatic-vessels-under-inflammatory-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology